NumerixS Investment Technologies’s Collegium Pharmaceutical COLL Stock Holding History

NumerixS Investment Technologies’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,900	Closed	-$47K	–	1100
2020 Q1	$47K	Buy	+2,900	New	+$59.9K	0.02%	624
2019 Q2	–	Sell	-23,582	Closed	-$370K	–	1110
2019 Q1	$370K	Buy	23,582 +14,891	+171%	+$238K	0.05%	455
2018 Q4	$144K	Sell	8,691 -1,609	-16%	-$27.5K	0.05%	442
2018 Q3	$153K	Buy	+10,300	New	+$183K	0.03%	682
2018 Q1	–	Sell	-1,500	Closed	-$28K	–	1075
2017 Q4	$28K	Buy	+1,500	New	+$21.5K	0.01%	956

Other funds holding COLL

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

NumerixS Investment Technologies's COLL Position: Q2 2020 in Review

NumerixS Investment Technologies sold out of Collegium Pharmaceutical (COLL) in Q2 2020, closing a stake of 2,900 shares — an estimated $47K sold.

NumerixS Investment Technologies first reported a position in COLL in Q4 2017 and held it in 5 quarters. The position peaked at $370K in Q1 2019. 150 funds tracked by Wall St. Rank hold COLL as of Q2 2020.

NumerixS Investment Technologies reported no remaining Collegium Pharmaceutical position as of Q2 2020 after selling out during the quarter.
NumerixS Investment Technologies sold 2,900 Collegium Pharmaceutical shares in Q2 2020, an estimated $47K.
NumerixS Investment Technologies first reported a position in Collegium Pharmaceutical in Q4 2017 and held it in 5 quarters.
NumerixS Investment Technologies's Collegium Pharmaceutical position peaked at $370K in Q1 2019.
150 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2020.

Based on NumerixS Investment Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.